11938 related articles for article (PubMed ID: 11241258)
21. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
Shah BK; Khanal A
Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
[TBL] [Abstract][Full Text] [Related]
22. Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden.
Lorenzo Bermejo J; Pukkala E; Johannesen TB; Sundquist J; Hemminki K
Br J Haematol; 2014 Mar; 164(5):675-83. PubMed ID: 24528128
[TBL] [Abstract][Full Text] [Related]
23. Second cancers among long-term survivors of non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Glimelius B; Holowaty E; Van Leeuwen FE; Lynch CF; Adami J; Gospodarowicz M; Wacholder S; Inskip P
J Natl Cancer Inst; 1993 Dec; 85(23):1932-7. PubMed ID: 8230284
[TBL] [Abstract][Full Text] [Related]
24. Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers.
Kim CJ; Freedman DM; Curtis RE; Berrington de Gonzalez A; Morton LM
Leuk Lymphoma; 2013 Aug; 54(8):1691-7. PubMed ID: 23193978
[TBL] [Abstract][Full Text] [Related]
25. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
[TBL] [Abstract][Full Text] [Related]
26. Joint occurrence of Merkel cell carcinoma and non-Hodgkin lymphomas in four Nordic countries.
Koljonen V; Rantanen M; Sahi H; Mellemkjær L; Hansen BT; Chen T; Hemminki K; Pukkala E
Leuk Lymphoma; 2015; 56(12):3315-9. PubMed ID: 25899400
[TBL] [Abstract][Full Text] [Related]
27. Skin cancer and non-Hodgkin's lymphoma: examining the link.
Hu S; Federman DG; Ma F; Kirsner RS
Dermatol Surg; 2005 Jan; 31(1):76-82. PubMed ID: 15720100
[TBL] [Abstract][Full Text] [Related]
28. Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota.
Brewer JD; Shanafelt TD; Khezri F; Sosa Seda IM; Zubair AS; Baum CL; Arpey CJ; Cerhan JR; Call TG; Roenigk RK; Smith CY; Weaver AL; Otley CC
J Am Acad Dermatol; 2015 Feb; 72(2):302-9. PubMed ID: 25479909
[TBL] [Abstract][Full Text] [Related]
29. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study.
Dudley IM; Sunguc C; Heymer EJ; Winter DL; Teepen JC; Belle FN; Bárdi E; Bagnasco F; Gudmundsdottir T; Skinner R; Michel G; Byrne J; Øfstaas H; Jankovic M; Mazić MČ; Mader L; Loonen J; Garwicz S; Wiebe T; Alessi D; Allodji RS; Haddy N; Grabow D; Kaatsch P; Kaiser M; Maule MM; Jakab Z; Gunnes MW; Terenziani M; Zaletel LZ; Kuehni CE; Haupt R; de Vathaire F; Kremer LC; Lähteenmäki PM; Winther JF; Hjorth L; Hawkins MM; Reulen RC
Cancer; 2023 Feb; 129(3):426-440. PubMed ID: 36444554
[TBL] [Abstract][Full Text] [Related]
30. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
[TBL] [Abstract][Full Text] [Related]
31. Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients.
Crocetti E; Carli P
Eur J Cancer Prev; 2004 Feb; 13(1):33-7. PubMed ID: 15075786
[TBL] [Abstract][Full Text] [Related]
32. Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
Cheng Y; Huang Z; Liao Q; Yu X; Jiang H; He Y; Yao S; Nie S; Liu L
PLoS One; 2020; 15(6):e0232800. PubMed ID: 32497148
[TBL] [Abstract][Full Text] [Related]
33. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors.
Goggins WB; Tsao H
Cancer; 2003 Feb; 97(3):639-43. PubMed ID: 12548605
[TBL] [Abstract][Full Text] [Related]
34. Malignant melanoma of the skin and non-Hodgkin's lymphoma in USA: a comparative epidemiological study.
Dimitrov B
Folia Med (Plovdiv); 1999; 41(1):121-5. PubMed ID: 10462940
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic radiation for lymphoma: risk of malignant mesothelioma.
Teta MJ; Lau E; Sceurman BK; Wagner ME
Cancer; 2007 Apr; 109(7):1432-8. PubMed ID: 17315168
[TBL] [Abstract][Full Text] [Related]
36. Increased risk of second primary cancers after a diagnosis of melanoma.
Bradford PT; Freedman DM; Goldstein AM; Tucker MA
Arch Dermatol; 2010 Mar; 146(3):265-72. PubMed ID: 20231496
[TBL] [Abstract][Full Text] [Related]
37. Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction.
Chattopadhyay S; Sud A; Zheng G; Yu H; Sundquist K; Sundquist J; Försti A; Houlston R; Hemminki A; Hemminki K
Int J Cancer; 2018 Nov; 143(10):2449-2457. PubMed ID: 30238973
[TBL] [Abstract][Full Text] [Related]
38. Non-Hodgkin's lymphoma.
Greiner TC; Medeiros LJ; Jaffe ES
Cancer; 1995 Jan; 75(1 Suppl):370-80. PubMed ID: 8001008
[TBL] [Abstract][Full Text] [Related]
39. Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality.
Parsons MW; Rock C; Chipman JJ; Shah HR; Hu B; Stephens DM; Tao R; Tward JD; Gaffney DK
Cancer Med; 2023 Feb; 12(3):2624-2636. PubMed ID: 36812123
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma.
Chang ET; Lau EC; Mowat FS; Teta MJ
Cancer Causes Control; 2017 Sep; 28(9):971-979. PubMed ID: 28755241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]